Insider · CIK 0001529708

Nanavaty Maulik

Reports to the SEC for 2 companies · NATICK, MA

sec.gov

Transactions

Companies

Filings

CIK

0001529708

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-05-28	RANIRani Therapeutics Holdings, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2024-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−101K sh	—	—	0
2024-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+101K sh	—	—	101,276
2024-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.4K sh	—	—	0
2024-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15.4K sh	—	—	79,317
2024-05-29	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2023-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−101K sh	—	—	0
2023-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+101K sh	—	—	101,276
2023-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.4K sh	—	—	63,894
2023-12-16	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15.4K sh	—	—	15,423
2023-11-16	RANIRani Therapeutics Holdings, Inc.P Purchase	Director	PPurchase	+500 sh	$1.98	+$990	500
2023-05-25	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+101K sh	—	—	101,276
2022-05-25	RANIRani Therapeutics Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+41.4K sh	—	—	41,416
2022-02-28	BSXBOSTON SCIENTIFIC CORPF Tax Payment	SVP & Pres, Neuromodulation	FTax Payment	−564 sh	$44.17	−$24.9K	177,258
2022-02-28	BSXBOSTON SCIENTIFIC CORP · Deferred Stock UnitsM Exercise/Conversion	SVP & Pres, Neuromodulation	MExercise/Conversion	−1,630 sh	—	—	0
2022-02-28	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	SVP & Pres, Neuromodulation	MExercise/Conversion	+1,630 sh	—	—	177,822
2022-02-22	BSXBOSTON SCIENTIFIC CORP · Performance Share UnitsA Award	SVP & Pres, Neuromodulation	AAward	+11.3K sh	—	—	11,335
2022-02-21	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	SVP & Pres, Neuromodulation	MExercise/Conversion	+1,714 sh	—	—	176,785
2022-02-21	BSXBOSTON SCIENTIFIC CORPF Tax Payment	SVP & Pres, Neuromodulation	FTax Payment	−593 sh	$42.55	−$25.2K	176,192
2022-02-21	BSXBOSTON SCIENTIFIC CORP · Deferred Stock UnitsM Exercise/Conversion	SVP & Pres, Neuromodulation	MExercise/Conversion	−1,714 sh	—	—	1,714
2022-02-18	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	SVP & Pres, Neuromodulation	MExercise/Conversion	+1,779 sh	—	—	175,687
2022-02-18	BSXBOSTON SCIENTIFIC CORPF Tax Payment	SVP & Pres, Neuromodulation	FTax Payment	−616 sh	$42.55	−$26.2K	175,071
2022-02-18	BSXBOSTON SCIENTIFIC CORP · Deferred Stock UnitsM Exercise/Conversion	SVP & Pres, Neuromodulation	MExercise/Conversion	−1,779 sh	—	—	3,558
2022-02-17	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	SVP & Pres, Neuromodulation	MExercise/Conversion	+2,166 sh	—	—	174,658
2022-02-17	BSXBOSTON SCIENTIFIC CORPF Tax Payment	SVP & Pres, Neuromodulation	FTax Payment	−750 sh	$42.83	−$32.1K	173,908
2022-02-17	BSXBOSTON SCIENTIFIC CORP · Restricted Stock UnitsM Exercise/Conversion	SVP & Pres, Neuromodulation	MExercise/Conversion	−2,166 sh	—	—	6,500
2022-02-16	BSXBOSTON SCIENTIFIC CORP · Restricted Stock UnitsA Award	SVP & Pres, Neuromodulation	AAward	+7,354 sh	—	—	7,354
2022-02-16	BSXBOSTON SCIENTIFIC CORP · Stock Option (Right to Buy)A Award	SVP & Pres, Neuromodulation	AAward	+21K sh	—	—	21,029
2022-02-15	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	SVP & Pres, Neuromodulation	MExercise/Conversion	+1,661 sh	—	—	173,067
2022-02-15	BSXBOSTON SCIENTIFIC CORPF Tax Payment	SVP & Pres, Neuromodulation	FTax Payment	−575 sh	$44.01	−$25.3K	172,492
2022-02-15	BSXBOSTON SCIENTIFIC CORP · Deferred Stock UnitsM Exercise/Conversion	SVP & Pres, Neuromodulation	MExercise/Conversion	−1,661 sh	—	—	1,661
2022-02-03	RANIRani Therapeutics Holdings, Inc.J Other	Director	JOther	+11K sh	—	—	11,017
2022-01-01	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	SVP & Pres, Neuromodulation	MExercise/Conversion	+6,175 sh	—	—	173,752
2022-01-01	BSXBOSTON SCIENTIFIC CORPF Tax Payment	SVP & Pres, Neuromodulation	FTax Payment	−2,346 sh	$42.48	−$99.7K	171,406
2022-01-01	BSXBOSTON SCIENTIFIC CORP · Performance Share UnitsM Exercise/Conversion	SVP & Pres, Neuromodulation	MExercise/Conversion	−6,175 sh	—	—	0
2021-08-02	BSXBOSTON SCIENTIFIC CORP · Stock Option (Right to Buy)A Award	SVP & Pres, Neuromodulation	AAward	+35K sh	—	—	34,965
2021-05-28	BSXBOSTON SCIENTIFIC CORPS Sale	SVP & Pres, Neuromodulation	SSale	−78.2K sh	$42.59	−$3.33M	166,869
2021-02-28	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	SVP & Pres, Neuromodulation	MExercise/Conversion	+1,629 sh	—	—	245,625
2021-02-28	BSXBOSTON SCIENTIFIC CORPF Tax Payment	SVP & Pres, Neuromodulation	FTax Payment	−564 sh	$38.78	−$21.9K	245,061
2021-02-28	BSXBOSTON SCIENTIFIC CORP · Deferred Stock UnitsM Exercise/Conversion	SVP & Pres, Neuromodulation	MExercise/Conversion	−1,629 sh	—	—	1,630
2021-02-22	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	SVP & Pres, Neuromodulation	MExercise/Conversion	+1,883 sh	—	—	244,648
2021-02-22	BSXBOSTON SCIENTIFIC CORPF Tax Payment	SVP & Pres, Neuromodulation	FTax Payment	−652 sh	$39.20	−$25.6K	243,996
2021-02-22	BSXBOSTON SCIENTIFIC CORP · Deferred Stock UnitsM Exercise/Conversion	SVP & Pres, Neuromodulation	MExercise/Conversion	−1,883 sh	—	—	0
2021-02-22	BSXBOSTON SCIENTIFIC CORP · Performance Share UnitsA Award	SVP & Pres, Neuromodulation	AAward	+6,303 sh	—	—	6,303
2021-02-21	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	SVP & Pres, Neuromodulation	MExercise/Conversion	+1,713 sh	—	—	243,358
2021-02-21	BSXBOSTON SCIENTIFIC CORPF Tax Payment	SVP & Pres, Neuromodulation	FTax Payment	−593 sh	$38.03	−$22.6K	242,765
2021-02-21	BSXBOSTON SCIENTIFIC CORP · Deferred Stock UnitsM Exercise/Conversion	SVP & Pres, Neuromodulation	MExercise/Conversion	−1,713 sh	—	—	3,428
2021-02-18	BSXBOSTON SCIENTIFIC CORPM Exercise/Conversion	SVP & Pres, Neuromodulation	MExercise/Conversion	+1,778 sh	—	—	242,260
2021-02-18	BSXBOSTON SCIENTIFIC CORPF Tax Payment	SVP & Pres, Neuromodulation	FTax Payment	−615 sh	$37.52	−$23.1K	241,645
2021-02-18	BSXBOSTON SCIENTIFIC CORP · Deferred Stock UnitsM Exercise/Conversion	SVP & Pres, Neuromodulation	MExercise/Conversion	−1,778 sh	—	—	5,337

Recent filings

Accepted (ET)
May 304
Nanavaty Maulik0001415889-25-015039
SEC(opens sec.gov)
Dec 174
Nanavaty Maulik0000950170-24-137313
SEC(opens sec.gov)
May 304
Nanavaty Maulik0000950170-24-066581
SEC(opens sec.gov)
Dec 194
Nanavaty Maulik0000950170-23-071468
SEC(opens sec.gov)
Nov 204
Nanavaty Maulik0000950170-23-064982
SEC(opens sec.gov)
May 304
Nanavaty Maulik0001209191-23-033047
SEC(opens sec.gov)
May 274
Nanavaty Maulik0000899243-22-019858
SEC(opens sec.gov)
Mar 24
Nanavaty Maulik0001225208-22-003865
SEC(opens sec.gov)
Feb 244
Nanavaty Maulik0001225208-22-003297
SEC(opens sec.gov)
Feb 234
Nanavaty Maulik0001225208-22-003085
SEC(opens sec.gov)

Companies

Address

ONE BOSTON SCIENTIFIC PLACE

NATICK, MA, 01760-1537